Key result
In older patients with non-ST elevation acute coronary syndromes, invasive revascularisation combined with optimal medical therapy is recommended for those at high risk of future cardiovascular events.
Why the study?
Does invasive revascularisation plus optimal medical therapy improve outcomes compared to optimal medical therapy alone in older patients with non-ST elevation acute coronary syndromes?
Does invasive revascularisation plus optimal medical therapy improve outcomes compared to optimal medical therapy alone in older patients with non-ST elevation acute coronary syndromes?
Accurate risk stratification is essential in older patients with NSTE-ACS to appropriately select candidates for invasive revascularization versus medical therapy alone.
Answers are grounded in this paper and cite their sources.
Supports risk-stratified invasive decisions in older NSTE-ACS; leaves open definitive outcome benefits versus medical therapy alone.
With an ageing population, older patients with non-ST elevation acute coronary syndrome are at higher risk of adverse outcomes but are far less likely to receive invasive revascularisation, contemporary antiplatelet therapy or drug-eluting stents than their younger counterparts. Accurate risk stratification in the older age groups may aid individualised decision-making with respect to identifying which patients will benefit most from invasive revascularisation, but more research is needed in this field. Based on current knowledge in this field, it would be appropriate following risk stratification to offer optimal medical therapy plus invasive care to older patients at high risk of future cardiovascular events but at low risk of complications and to offer optimal medical therapy alone to those who are deemed low risk of future events with high risk of developing procedural complications and severely frail patients.
No takes yet. Share an insight, caveat, or question.
Sinclair et al. (2016) conducted a review in non-ST elevation acute coronary syndromes. Invasive revascularisation vs. Optimal medical therapy alone was evaluated. In older patients with non-ST elevation acute coronary syndromes, invasive revascularisation combined with optimal medical therapy is recommended for those at high risk of future cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: